Matches in Wikidata for { <http://www.wikidata.org/entity/Q57453068> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q57453068 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q57453068 description "im Dezember 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57453068 description "scientific article published on 01 December 2018" @default.
- Q57453068 description "wetenschappelijk artikel" @default.
- Q57453068 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57453068 name "Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience" @default.
- Q57453068 name "Correction to: Liver Safety of Fasiglifam" @default.
- Q57453068 type Item @default.
- Q57453068 label "Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience" @default.
- Q57453068 label "Correction to: Liver Safety of Fasiglifam" @default.
- Q57453068 prefLabel "Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience" @default.
- Q57453068 prefLabel "Correction to: Liver Safety of Fasiglifam" @default.
- Q57453068 P1433 Q57453068-D53B19D7-359D-49E2-8AB4-C13B5A3F1FB5 @default.
- Q57453068 P1476 Q57453068-19BD3CAB-24C3-4DA5-8E5C-0CAD465F7980 @default.
- Q57453068 P2093 Q57453068-0964C9CF-DE60-4434-9C6C-3F95E12413A9 @default.
- Q57453068 P2093 Q57453068-36CD25A1-C191-47C6-BEA8-4B7CB23A2146 @default.
- Q57453068 P2093 Q57453068-515D4D06-E0C5-4DD4-88DE-C6BE420C6AEC @default.
- Q57453068 P2093 Q57453068-6DCE7E3F-55A3-4566-AD17-065E0ADE80A7 @default.
- Q57453068 P304 Q57453068-69229FFA-BFAB-4F3D-8D11-94F77E7CD7AF @default.
- Q57453068 P31 Q57453068-9DE9D709-11C2-4015-B797-2FADDF3B8E39 @default.
- Q57453068 P31 Q57453068-CACF5C6C-B496-47CD-885E-5576606224CA @default.
- Q57453068 P356 Q57453068-A133EEDF-0C40-4160-919F-9B1CB55568B2 @default.
- Q57453068 P407 Q57453068-BDFA8970-CAA8-48F6-9A88-4F93E2845BFC @default.
- Q57453068 P433 Q57453068-C5144DD8-EBCD-4683-8115-E3F8A254F0B6 @default.
- Q57453068 P478 Q57453068-2F171D40-A8C2-49F9-875A-430068EB3949 @default.
- Q57453068 P50 Q57453068-7B16AB55-5C4F-4FCB-905C-329A0F18D1D1 @default.
- Q57453068 P577 Q57453068-2B001BE3-6BDB-4A28-BAB6-9472B9F510D1 @default.
- Q57453068 P698 Q57453068-9C8992C7-35B6-4647-9905-D9D0E46C53D1 @default.
- Q57453068 P921 Q57453068-B223A42C-7E32-4965-979E-7BE2D60AE843 @default.
- Q57453068 P356 S40264-018-0745-0 @default.
- Q57453068 P698 30328587 @default.
- Q57453068 P1433 Q15724462 @default.
- Q57453068 P1476 "Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience" @default.
- Q57453068 P2093 "Melvin S Munsaka" @default.
- Q57453068 P2093 "Neila Smith" @default.
- Q57453068 P2093 "Paul B Watkins" @default.
- Q57453068 P2093 "Takashi Ohira" @default.
- Q57453068 P304 "1431-1437" @default.
- Q57453068 P31 Q13442814 @default.
- Q57453068 P31 Q1348305 @default.
- Q57453068 P356 "10.1007/S40264-018-0745-0" @default.
- Q57453068 P407 Q1860 @default.
- Q57453068 P433 "12" @default.
- Q57453068 P478 "41" @default.
- Q57453068 P50 Q87904161 @default.
- Q57453068 P577 "2018-12-01T00:00:00Z" @default.
- Q57453068 P698 "30328587" @default.
- Q57453068 P921 Q3025883 @default.